|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 31/397 | (2006.01) |
| (11) | Number of the document | 2661261 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12700262.4 |
| Date of filing the European patent application | 2012-01-05 | |
| (97) | Date of publication of the European application | 2013-11-13 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-31 |
| (46) | Date of publication of the claims translation | 2019-10-25 |
| (86) | Number | PCT/EP2012/050151 |
| Date | 2012-01-05 |
| (87) | Number | WO 2012/093161 |
| Date | 2012-07-12 |
| (30) | Number | Date | Country code |
| 11150431 | 2011-01-07 | EP |
| (72) |
BOUILLOT, Philippe, CH
REYNAUD, Emeric, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Imunosupresantų kompozicijos |
| IMMUNOSUPPRESSANT FORMULATIONS |
| Payment date | Validity (years) | Amount | |
| 2024-12-18 | 14 | 289.00 EUR |
| 2026-01-05 |